Mereo BioPharma Group
MREO· Manufacturing· Fiscal year ends in December
CEO pay in FY2025Stock -88.1% in FY2025
Dr. Denise Scots-Knight is the CEO of Mereo BioPharma Group and was paid $2.7M in FY2025 (Dec), down 14%.
Pay$100 in the stock at the end of FY22 → $56
Executives3
See all- 1Dr. Denise Scots-KnightChief Executive OfficerFY2025
- 2Charles SermonGeneral CounselFY2025
- 3Christine FoxChief Financial OfficerFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allMereo BioPharma Group paid its 3 named executives $5.0M in total in FY2025 (Dec). CEO Dr. Denise Scots-Knight was paid $2.7M of that.
| Name | |||
|---|---|---|---|
| Dr. Denise Scots-KnightChief Executive Officer | |||
| Charles SermonGeneral Counsel | |||
| Christine FoxChief Financial Officer |
of each named executive, from the Summary Compensation Table of each proxy.
Peers
No disclosed peer group
No proxy on file names a pay peer group for Mereo BioPharma Group. The peer group comes from the proxy statement, so it shows here when a proxy read has it.
Board5
See all- Anders EkblomDirector · 9 yr on the boardIndependentRemuneration (Chair), Research and Development (Chair)—Paid as an executive
- Jeremy BenderDirector · 4 yr on the boardIndependentAudit and Risk, Nomination and Corporate Governance—Paid as an executive
- Annalisa JenkinsDirector · 2 yr on the boardIndependentAudit and Risk—Paid as an executive
- Daniel ShamesDirector · 2 yr on the boardIndependentResearch and Development—Paid as an executive
- Justin RobertsDirector · 2 yr on the boardIndependentNomination and Corporate Governance, Remuneration—Paid as an executive
The board of the latest proxy (FY2024).
Activity
Filings6
See all| Proxy statement | DEF 14A | Apr 9, 2026 | FY2025 |
| Annual report | 10-K | Mar 19, 2026 | FY2025 |
| Proxy statement | DEF 14A | Apr 8, 2025 | FY2024 |
| Annual report | 10-K | Mar 26, 2025 | FY2024 |
| Proxy statement | DEF 14A | Apr 24, 2024 | FY2023 |
| Annual report | 10-K | Mar 27, 2024 | FY2023 |